Clinical Trial Type: Breast

Name of this trial: MK-2870-011 (TroFuse-011)  What type of cancer is this for? Triple-Negative Breast Cancer  Who is this trial for? Patients With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer  What biomarkers are involved? Expressing PD-L1 at CPS Less Than 10  What is the National Clinical Trial #? NCT06841354; https://clinicaltrials.gov/study/NCT06841354  Brief summary of this trial: A Phase 3, Randomized, Open-label